Catherine Munera

1.9k total citations
44 papers, 1.1k citations indexed

About

Catherine Munera is a scholar working on Physiology, Dermatology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Catherine Munera has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Physiology, 21 papers in Dermatology and 14 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Catherine Munera's work include Dermatology and Skin Diseases (21 papers), Pain Mechanisms and Treatments (14 papers) and Opioid Use Disorder Treatment (14 papers). Catherine Munera is often cited by papers focused on Dermatology and Skin Diseases (21 papers), Pain Mechanisms and Treatments (14 papers) and Opioid Use Disorder Treatment (14 papers). Catherine Munera collaborates with scholars based in United States, Canada and Germany. Catherine Munera's co-authors include Warren Wen, Frédérique Menzaghi, Steven Fishbane, Craig Landau, Steven R. Ripa, Roger Echols, Abdollah Iravani, Ira Klimberg, Steven F. Kowalsky and Robert F Coniff and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and Journal of Allergy and Clinical Immunology.

In The Last Decade

Catherine Munera

42 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Catherine Munera United States	18	360	349	228	226	222	44	1.1k
David Upmalis United States	16	19 0.1×	380 1.1×	298 1.3×	23 0.1×	423 1.9×	38	1.1k
René Kerstens Belgium	25	27 0.1×	322 0.9×	46 0.2×	151 0.7×	17 0.1×	65	2.7k
Michael Butler Canada	17	211 0.6×	40 0.1×	135 0.6×	15 0.1×	152 0.7×	51	796
Lori E. Shapiro Canada	17	309 0.9×	90 0.3×	20 0.1×	246 1.1×	10 0.0×	27	1.1k
A.A. Ajayi Nigeria	21	87 0.2×	148 0.4×	82 0.4×	82 0.4×	3 0.0×	69	1.2k
James W. Mims United States	10	63 0.2×	460 1.3×	77 0.3×	17 0.1×	34 0.2×	24	873
Ferhat Çatal Türkiye	18	101 0.3×	146 0.4×	75 0.3×	46 0.2×	3 0.0×	57	871
A. Collier United Kingdom	21	46 0.1×	178 0.5×	114 0.5×	39 0.2×	4 0.0×	49	1.2k
Yun Mi Yu South Korea	13	94 0.3×	62 0.2×	28 0.1×	16 0.1×	11 0.0×	50	563
Kamıl Dilek Türkiye	17	27 0.1×	62 0.2×	44 0.2×	154 0.7×	8 0.0×	63	846

Countries citing papers authored by Catherine Munera

Since Specialization

Citations

This map shows the geographic impact of Catherine Munera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Munera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Munera more than expected).

Fields of papers citing papers by Catherine Munera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Munera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Munera. The network helps show where Catherine Munera may publish in the future.

Co-authorship network of co-authors of Catherine Munera

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Munera. A scholar is included among the top collaborators of Catherine Munera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Munera. Catherine Munera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Brian, Sonja Ständer, Kenji Kabashima, et al.. (2024). Notalgia Paresthetica Dermatologist Report of Symptom Burden and Treatment: Results from a Physician Survey. Acta Dermato Venereologica. 104. adv39941–adv39941. 2 indexed citations

Guttman‐Yassky, Emma, Paola Facheris, Joel Corrêa da Rosa, et al.. (2023). Oral difelikefalin reduces moderate to severe pruritus and expression of pruritic and inflammatory biomarkers in subjects with atopic dermatitis. Journal of Allergy and Clinical Immunology. 152(4). 916–926. 16 indexed citations

Spencer, Robert H., Catherine Munera, Megan J. Shram, & Frédérique Menzaghi. (2023). Assessment of the physical dependence potential of difelikefalin: Randomized placebo‐controlled study in patients receiving hemodialysis. Clinical and Translational Science. 16(9). 1559–1568. 6 indexed citations

Yosipovitch, Gil, et al.. (2023). A phase 2 study of oral difelikefalin in subjects with chronic kidney disease and moderate-to-severe pruritus. Journal of the American Academy of Dermatology. 89(2). 261–268. 17 indexed citations

Menzaghi, Frédérique, et al.. (2023). The Burden of Pruritus Associated With CKD: A Mixed Methods Analysis Among Patients Undergoing Dialysis. Kidney Medicine. 5(9). 100696–100696. 5 indexed citations

Topf, Joel Michels, Thomas D. Wooldridge, Michael Schömig, et al.. (2022). Efficacy of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis of KALM-1 and KALM-2 Phase 3 Studies. Kidney Medicine. 4(8). 100512–100512. 39 indexed citations

Fishbane, Steven, et al.. (2022). Safety and Tolerability of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis From the Phase 3 Clinical Trial Program. Kidney Medicine. 4(8). 100513–100513. 24 indexed citations

Weiner, Daniel E., Marc Vervloet, Sebastian Walpen, et al.. (2022). Safety and Effectiveness of Difelikefalin in Patients With Moderate-to-Severe Pruritus Undergoing Hemodialysis: An Open-Label, Multicenter Study. Kidney Medicine. 4(10). 100542–100542. 13 indexed citations

Bacci, Elizabeth D., Rozanne Wilson, Brooke M. Currie, et al.. (2022). Understanding the patient experience of living with notalgia paresthetica: A qualitative interview study. JAAD International. 8. 94–101. 8 indexed citations

10.

Vernon, Margaret, Rebecca M. Speck, Catherine Munera, et al.. (2021). Psychometric validation and meaningful change thresholds of the Worst Itching Intensity Numerical Rating Scale for assessing itch in patients with chronic kidney disease-associated pruritus. Journal of Patient-Reported Outcomes. 5(1). 134–134. 20 indexed citations

11.

Vernon, Margaret, Sonja Ständer, Catherine Munera, Robert H. Spencer, & Frédérique Menzaghi. (2020). Clinically meaningful change in itch intensity scores: An evaluation in patients with chronic kidney disease–associated pruritus. Journal of the American Academy of Dermatology. 84(4). 1132–1134. 20 indexed citations

12.

Laber, Eric B., et al.. (2018). Identifying optimal dosage regimes under safety constraints: An application to long term opioid treatment of chronic pain. Statistics in Medicine. 37(9). 1407–1418. 12 indexed citations

13.

Ripa, Steven R., Bill McCarberg, Catherine Munera, Warren Wen, & Craig Landau. (2012). A randomized, 14-day, double-blind study evaluating conversion from hydrocodone/acetaminophen (Vicodin) to buprenorphine transdermal system 10 μg/h or 20 μg/h in patients with osteoarthritis pain. Expert Opinion on Pharmacotherapy. 13(9). 1229–1241. 11 indexed citations

14.

Munera, Catherine, Margaret Drehobl, Nelson E. Sessler, & Craig Landau. (2011). A randomized, placebo-controlled, double-blinded, parallel-group, 5-week study of buprenorphine transdermal system in adults with osteoarthritis. Journal of Opioid Management. 6(3). 193–202. 32 indexed citations

15.

Steiner, Deborah, Catherine Munera, M. Hale, Steven R. Ripa, & Craig Landau. (2011). Efficacy and Safety of Buprenorphine Transdermal System (BTDS) for Chronic Moderate to Severe Low Back Pain: A Randomized, Double-Blind Study. Journal of Pain. 12(11). 1163–1173. 65 indexed citations

16.

Steiner, Deborah J., et al.. (2011). Efficacy and Safety of the Seven-Day Buprenorphine Transdermal System in Opioid-Naïve Patients with Moderate to Severe Chronic Low Back Pain: An Enriched, Randomized, Double-Blind, Placebo-Controlled Study. Journal of Pain and Symptom Management. 42(6). 903–917. 86 indexed citations

17.

Steiner, Deborah, et al.. (2009). The efficacy and safety of buprenorphine transdermal system (BTDS) in subjects with moderate to severe low back pain: a double-blind study. Journal of Pain. 10(4). S51–S51. 5 indexed citations

18.

Landau, Craig, et al.. (2007). Buprenorphine Transdermal Delivery System in Adults with Persistent Noncancer-Related Pain Syndromes Who Require Opioid Therapy: A Multicenter, 5-Week Run-in and Randomized, Double-Blind Maintenance-of-Analgesia Study. Clinical Therapeutics. 29(10). 2179–2193. 45 indexed citations

19.

Lemmens, Hendrikus J. M., Daisuke Wada, Catherine Munera, Ahmed El‐Tahtawy, & Donald R. Stanski. (2005). Enriched analgesic efficacy studies: An assessment by clinical trial simulation. Contemporary Clinical Trials. 27(2). 165–173. 22 indexed citations

20.

Iravani, Abdollah, et al.. (1999). A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection. Journal of Antimicrobial Chemotherapy. 43(suppl_1). 67–75. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact